People have always been searching for the cosmetic Fountain of Youth—grey hairs are dyed, tummies are tucked, and wrinkles are Botoxed.
According to the Scottish company Pharmacells, these modern day Ponce de Leons may have an exciting development to celebrate as the company is about to start clinical trials of a treatment that uses stem cells derived from a patient’s own blood to eliminate wrinkles.
“The skin has a natural elastic property which comes from cells known as fibroblasts,” Athol Haas, the company’s chief executive, told the Telegraph’s Richard Gray.
“The ability of the body to produce this elastic material slows down with age because the number of these fibroblasts decreases,” he said. “By introducing large numbers of stem cells into the right place, we are increasing the ability of the body to produce this natural material. It will be long lasting, we think at least five years if not longer.”
Commercially using stem cells for skin care is actually being done today. However, the stem cells are derived from a sample of the patient’s fat cells, not their blood. According to Haas, his company’s treatment is superior to those that use fat-derived stem cells.
“The stem cells in fat are more mature so the quality is not so good, and the numbers of them in it are much smaller, around five or 10 million,” Haas explained. “We are talking about 500 million, very high quality, pure stem cells and there is definitely a link between dose and efficacy. The more you have, the better it should be.”